Open Access<p>Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors</p>
Author(s) -
Jialu Wu,
Hui Huang
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s270210
Subject(s) - pazopanib , axitinib , sunitinib , medicine , sorafenib , renal cell carcinoma , cabozantinib , tyrosine kinase inhibitor , oncology , tyrosine kinase , cancer , receptor , hepatocellular carcinoma
We analyze a number of studies that describe the relationship between the onset of hypothyroidism and the prognosis of patients with metastatic renal cell carcinoma (mRCC) treated with TKIs.